Japanese Pharmaceutical Company to Fight $6B in Punies

On Monday, a jury in Louisiana ordered Eli Lilly and Takeda, a Japanese pharmaceutical company, to pay $1.475M in compensatory damages and $9B in punies for concealing cancer risks in the diabetes drug Actos.  Takeda has announced it will fight the $6B punies verdict against it.  Because of the presumptive single-digit Due Process ratio, there is a strong possibility the punies will at least be reduced.  Cathy Sharkey (NYU) provides commentary in this Reuters piece.

–CJR